Hideyuki Migita

572 citations
11 papers · 487 indexed · h-index 10
Topics
CRISPR and Genetic Engineering (2 papers)Nuclear Receptors and Signaling (2 papers)Angiogenesis and VEGF in Cancer (2 papers)
Partner nations
JapanNorwayFrance

In The Last Decade

Hideyuki Migita

11 papers receiving 476 citations

Peers

Hideyuki Migita
Comparison fields: 5 of 76
  • Molecular Biology 257
  • Clinical Biochemistry 59
  • Endocrine and Autonomic Systems 53
  • Physiology 51
  • Immunology 51
Replace Ian Ocrant with:
Ian Ocrant United States
Brent A. Wilkerson United States
Kenta Magoori Japan
Kazuo Yagui Japan
Stacey Hose United States
Richard P. Kondo United States
Jocelyne Blanc France
Nadine Reichhart Germany
Michelle Yam Australia
Adina Makover Israel
Hideyuki Migita relative to Ian Ocrant United States Ian Ocrant's profile →
Citations per field
00.5×
Ian Ocrant · 1×
Citations per year

Countries citing papers authored by Hideyuki Migita

Since Specialization
Citations

This map shows the geographic impact of Hideyuki Migita's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hideyuki Migita with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hideyuki Migita more than expected).

Fields of papers citing papers by Hideyuki Migita

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hideyuki Migita. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hideyuki Migita. The network helps show where Hideyuki Migita may publish in the future.

Co-authorship network of co-authors of Hideyuki Migita

This figure shows the co-authorship network connecting the top 25 collaborators of Hideyuki Migita. A scholar is included among the top collaborators of Hideyuki Migita based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hideyuki Migita. Hideyuki Migita is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
#WorkIndexed citations
1 5
2 11
3 63
4 49
5 15
6 59
7 28
8 62
9 16
10 162
11 17

About Hideyuki Migita

Hideyuki Migita is a scholar working on Developmental Neuroscience, Physiology and Cancer Research, having authored 11 papers that have together received 487 indexed citations. Recurring topics across this work include CRISPR and Genetic Engineering (2 papers), Nuclear Receptors and Signaling (2 papers) and Angiogenesis and VEGF in Cancer (2 papers). The work is most often cited by research in Clinical Biochemistry (59 citations), Endocrine and Autonomic Systems (53 citations) and Physiology (24 citations). Hideyuki Migita has collaborated with scholars based in Japan, Norway and France. Frequent co-authors include John Morser, Sho‐ichi Yamagishi, Hiroshi Yamamoto, Shigeru Sakurai, Yasuhiko Yamamoto, Hideto Yonekura, Hiroyuki Unoki‐Kubota, Md. Joynal Abedin, Hua Wang and Xiaoxu Liu. Their work appears in journals such as Nucleic Acids Research, Journal of Biological Chemistry and FEBS Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026